Lungenkrebs gehört weltweit zu den häufigsten Krebserkrankungen und ist bekannt für seine oft späte Diagnosestellung, da Symptome in frühen Stadien meist unspezifisch oder gar nicht vorhanden sind. Blutwerte können dabei eine unterstützende Rolle spielen, indem sie Hinweise auf Veränderungen im Körper geben, die mit Lungenkrebs in Verbindung stehen könnten. Es ist jedoch wichtig zu betonen, dass Bluttests allein keine definitive Diagnose liefern, sondern immer im Kontext mit bildgebenden Verfahren wie Röntgen oder CT sowie einer Biopsie interpretiert werden müssen. In diesem Artikel beleuchten wir die wichtigsten Blutwerte, die bei Verdacht auf Lungenkrebs relevant sein könnten, und erklären, was sie über den Gesundheitszustand aussagen. Entzündungsmarker: CRP und BSG Ein erster Hinweis auf eine mögliche Krebserkrankung kann durch Entzündungsmarker im Blut gegeben werden. Das C-reaktive Protein (CRP) ist ein Eiweiß, das bei Entzündungen im Körper, einschließlich solcher, die durch Tumore ausgelöst werden,… 

The Ordinary Court of Turin has ordered the seizure of hundreds of allegedly counterfeit products marketed as „equivalent“ to the Rigenera® technology patented by Rigenera HBW, a leading Italian company in the field of regenerative medicine. This step has been taken in the midst of legal proceedings for the alleged violations of intellectual property rights and for the potential risk to the health of users due to the use of materials for non-medical use. The investigation began in 2021 following a complaint to the Italian authorities by Rigenera HBW. This warned of an international network of manufacturing and distribution of counterfeit devices, led by former partners and collaborators of the company, operating through companies in Italy, Ireland and Turkey mainly. The distribution network is spread across many countries of the GCC, including UAE and KSA, as well as Russia, Turkey,… 

The question of why the so-called „Epstein list“ has not been fully released as of February 25, 2025, is a complex one, steeped in legal, political, and social considerations. While hundreds of pages of court documents related to Jeffrey Epstein have already been unsealed over the past year, including names of associates, victims, and others tangentially connected to his case, the anticipation of a definitive „client list“ or further explosive revelations persists. Recent statements from U.S. Attorney General Pam Bondi, who hinted at reviewing a substantial stack of Epstein-related documents as recently as February 20, 2025, have fueled speculation. Yet, the release has not materialized. Below is an analysis of possible reasons for this delay, grounded in available context and reasonable inference. One potential reason is legal and procedural hurdles. The Epstein case involves a sprawling web of civil lawsuits,… 

A novel tool for rapidly identifying the genetic „fingerprints“ of cancer cells may enable future surgeons to more accurately remove brain tumors while a patient is in the operating room, new research reveals. Many cancer types can be identified by certain mutations, changes in the instructions encoded in the DNA of the abnormal cells. Led by a research team from NYU Langone Health, the new study describes the development of Ultra-Rapid droplet digital PCR, or UR-ddPCR, which the team found can measure the level of tumor cells in a tissue sample in only 15 minutes while also being able to detect small numbers of cancer cells (as few as five cells per square millimeter). The researchers say their tool is fast and accurate enough, at least in initial tests on brain tissue samples, to become the first practical tool of…